previously, clinical trials on GLP-1 drugs have demonstrated their Advantages for a secondary prevention Device for heart problems (CVD), that means they could reduce the likelihood of the coronary heart attack or https://europeantimes.news/2024/08/belgium-battle-drugs-alcohol-hope/